Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain

International Journal of Antimicrobial Agents

Volumn 30, Issue 2, 2007, Pages 183-185

  Alonso, Rodrigo ^a   Mateo, Estibaliz ^a   Ezpeleta, Guillermo ^b   Cisterna, Ramón ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

Author keywords

Fluoroquinolone; gyrA; parC; Resistance; Streptococcus pyogenes

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PHENYLALANINE; PROTEIN PARC; SERINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; CULTURE MEDIUM; DNA SEQUENCE; EMM GENE; GENE AMPLIFICATION; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SPAIN; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; OFLOXACIN; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 34250847101     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.04.001     Document Type: Article

References (17)

1. Albertí S., Cortés G., García-Rey C., et al. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity. Antimicrob Agents Chemother 49 (2005) 418-420
2. Richter S.S., Diekema D.J., Heilmann K.P., et al. Fluoroquinolone resistance in Streptococcus pyogenes. Clin Infect Dis 36 (2003) 380-383
3. Yan S.S., Fox M.L., Holland S.M., Stock F., Gill V.J., and Fedorko D.P. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob Agents Chemother 44 (2000) 3196-3198
4. Pérez-Trallero E., Fernández-Mazarrasa C., García-Rey C., et al. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 45 (2001) 3334-3340
5. Malhotra-Kumar S., Lammens C., Chaspelle S., Mallentjer C., Weyle J., and Goossens H. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J Antimicrob Chemother 55 (2005) 320-325
6. Alonso R., and Galimand M. Courvalin P. parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513. Antimicrob Agents Chemother 46 (2002) 3686-3687
7. Schmitz F.J., Boos M., Mayer S., Kohrer K., Scheuring S., and Fluit A.C. In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones. Antimicrob Agents Chemother 46 (2002) 934-935
8. Bast D.J., Low D.E., Duncan C.L., et al. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother 44 (2000) 3049-3054
9. Guerin F., Varon E., Hoi A.B., Gutmann L., and Podglajen I. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci. Antimicrob Agents Chemother 44 (2000) 2197-2200
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S15. Wayne, PA: CLSI; 2005.
11. Chatellier S., Ihendyane N., Kansal R.G., et al. Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68 (2000) 3523-3534
12. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
13. Hasenbein M.E., Warner J.E., Lambert K.G., Cole S.E., Onderdonk A.B., and McAdam A.J. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol 42 (2004) 1559-1563
14. Orscheln R.C., Johnson D.R., Olson S.M., et al. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J Infect Dis 191 (2005) 1272-1279
15. Reinert R.R., Lutticken R., and Al-Lahham A. High-level fluoroquinolone resistance in a clinical Streptococcus pyogenes isolate in Germany. Clin Microbiol Infect 10 (2004) 659-662
16. Rivera A., Rebollo M., Sánchez F., et al. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain. Clin Microbiol Infect 11 (2005) 759-761
17. O'Brien K.L., Beall B., Barret N.L., et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis 35 (2002) 268-276